EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management

Khaled S Allemailem iD, Saleh A Almatroodi iD, Ahmad Almatroudi iD, Faris Alrumaihi iD, Waleed Al Abdulmonem iD, Wafa Abdullah I Al-Megrin iD, Adel Nasser Aljamaan, Arshad Husain Rahmani, Amjad Ali Khan iD

International Journal of Molecular Sciences · 11.04.2023 · 24 (8) · 7052

DOI: 10.3390/ijms24087052 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.04.2023. Verfasst von Khaled S Allemailem und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Neoplasms. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The innovative advances in transforming clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR/Cas9) into different variants have taken the art of genome-editing specificity to new heights. Allosteric modulation of Cas9-targeting specificity by sgRNA sequence alterations and protospacer adjacent motif (PAM) modifications have been a good lesson to learn about specificity and activity scores in different Cas9 variants. Some of the high-fidelity Cas9 variants have been ranked as Sniper-Cas9, eSpCas9 (1.1), SpCas9-HF1, HypaCas9, xCas9, and evoCas9. However, the selection of an ideal Cas9 variant for a given target sequence remains a challenging task. A safe and efficient delivery system for the CRISPR/Cas9 complex at tumor target sites faces considerable challenges, and nanotechnology-based stimuli-responsive delivery approaches have significantly contributed to cancer management. Recent innovations in nanoformulation design, such as pH, glutathione (GSH), photo, thermal, and magnetic responsive systems, have modernized the art of CRISPR/Cas9 delivery approaches. These nanoformulations possess enhanced cellular internalization, endosomal membrane disruption/bypass, and controlled release. In this review, we aim to elaborate on different CRISPR/Cas9 variants and advances in stimuli-responsive nanoformulations for the specific delivery of this endonuclease system. Furthermore, the critical constraints of this endonuclease system on clinical translations towards the management of cancer and prospects are described.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsNeoplasmsHumansCRISPR-Associated Protein 9Gene EditingTechnology

Stichwörter der Autor:innen

CRISPR/Cas9Cas9 variantscancer therapyclinical trialgene expressionnanotechnologystimuli-responsive nanoformulationstumor microenvironment

Substanzen

CRISPR-Associated Protein 9

Autor:innen und Institutionen

  • Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.
  • Department of Pathology, College of Medicine, Qassim University, Buraydah 51452, Saudi Arabia.
  • Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
  • Medical Supply Department, Durma Hospital, Durma 11923, Saudi Arabia.
  • Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.

ORCID-Profile: Khaled S Allemailem, Saleh A Almatroodi, Ahmad Almatroudi, Faris Alrumaihi, Waleed Al Abdulmonem, Wafa Abdullah I Al-Megrin, Amjad Ali Khan

Zitieren

APA

Allemailem, K. S., Almatroodi, S. A., Almatroudi, A., Alrumaihi, F., Al Abdulmonem, W., Al-Megrin, W. A. I., Aljamaan, A. N., Rahmani, A. H., & Khan, A. A. (2023). Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management. International Journal of Molecular Sciences, 24(8), 7052. https://doi.org/10.3390/ijms24087052

Vancouver

Allemailem KS, Almatroodi SA, Almatroudi A, Alrumaihi F, Al Abdulmonem W, Al-Megrin WAI, et al. Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management. International Journal of Molecular Sciences. 2023;24(8):7052. doi:10.3390/ijms24087052

BibTeX
@article{Allemailem2023,
  author = {Allemailem, Khaled S and Almatroodi, Saleh A and Almatroudi, Ahmad and Alrumaihi, Faris and Al Abdulmonem, Waleed and Al-Megrin, Wafa Abdullah I and Aljamaan, Adel Nasser and Rahmani, Arshad Husain and Khan, Amjad Ali},
  title = {Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {8},
  pages = {7052},
  doi = {10.3390/ijms24087052}
}
Kostenlos starten →